Skip to main content

SIK1/Snf1lk Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-76571PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-76571PEP

Key Product Details

Source

Synthetic

Conjugate

Unconjugated

Applications

Antibody Competition

Product Specifications

Description

A blocking peptide containing 18 amino acids near the center of human SIK1.

Source: Synthetic

(Accession #: NP_775490)

Purity

N/A

Application Notes

This peptide is useful as a blocking peptide for NBP1-76571. For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NBP1-76571PEP
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
Preservative 0.02% Sodium Azide
Concentration 0.2 mg/ml
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -20C. Avoid freeze-thaw cycles.

Background: SIK1/Snf1lk

Transient role during the earliest stages of myocardial cell differentiation and/or primitive chamberformation and may also be important for the earliest stages of skeletal muscle growth and/or differentiation.Potential role in G2/M cell cycle regulation. Inhibits CREB activity by phosphorylating and repressing theCREB-specific coactivators, CRTC1-3

Long Name

Serine/threonine-protein kinase SIK1

Alternate Names

SIK-1, SIK1, SNF1LK

Gene Symbol

SIK1

Additional SIK1/Snf1lk Products

Product Documents for SIK1/Snf1lk Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SIK1/Snf1lk Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...